ANAB
AnaptysBio Inc
46.20$
+1.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | 100.0% | – | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 102.1% | 182.1% | – | 102.9% | 95.7% | 253.5% | 393.7% | – | 357.7% | – | – | 547.0% | – | 714.2% | 139.8% | – | – | 35.9% | 215.0% | 84.3% | 106.4% | 2,648.5% | 2,321.2% | 1,714.1% | 1,706.4% | 343.3% | 2,544.2% | 951.5% | 930.6% | 372.3% | 516.0% | 382.8% | 140.6% | 98.8% | 148.3% | 169.9% | 41.2% | -99.8% | 2.4% | 9.8% | -30.8% | |
| -2.1% | -82.1% | – | -2.9% | -95.7% | -153.5% | -393.7% | – | -257.7% | – | – | -447.0% | – | -614.2% | -39.8% | – | – | 64.1% | -115.0% | 15.7% | -6.4% | -2,548.5% | -2,221.2% | -1,614.1% | -1,606.4% | -243.3% | -2,444.2% | -851.5% | -830.6% | -272.3% | -416.0% | -282.8% | -40.6% | 1.2% | -48.3% | -69.9% | 58.8% | 199.8% | 97.6% | 109.8% | 133.1% | |
| 201.7% | 218.4% | – | 111.5% | 98.5% | 256.9% | 393.7% | – | 357.7% | – | – | 547.0% | – | 714.2% | 139.8% | – | – | 35.9% | 215.0% | 84.3% | 106.4% | 2,648.5% | 2,321.2% | 1,714.1% | 1,706.4% | 343.3% | 2,544.2% | 951.5% | 930.6% | 453.8% | 516.0% | 382.8% | 140.6% | 98.8% | 148.3% | 169.9% | 41.2% | 23.6% | 132.5% | 9.8% | 39.4% | |
| 31.3% | 33.1% | – | 33.6% | 34.1% | 84.8% | 131.6% | – | 80.1% | – | – | 86.1% | – | 127.7% | 28.6% | – | – | 8.5% | 48.2% | 17.5% | 26.0% | 533.3% | 722.0% | 672.0% | 685.4% | 138.2% | 787.3% | 308.7% | 306.6% | 114.1% | 171.9% | 84.7% | 35.2% | 23.6% | 50.9% | 47.7% | 13.4% | 14.6% | 102.5% | 58.4% | 28.7% | |
| 31.3% | 33.1% | – | 33.6% | 34.1% | 84.8% | 131.6% | – | 80.1% | – | – | 86.1% | – | 127.7% | 28.6% | – | – | 8.5% | 48.2% | 17.5% | 26.0% | 533.3% | 1,051.9% | 672.0% | 685.4% | 138.2% | 787.3% | 308.7% | 306.6% | 195.6% | 171.9% | 84.7% | 35.2% | 23.6% | 50.9% | 47.7% | 13.4% | 138.0% | 233.1% | 38.7% | 96.7% | |
| -33.4% | -115.3% | – | -36.5% | -129.8% | -238.4% | -525.2% | – | -337.7% | – | – | -535.1% | – | -741.9% | -68.4% | – | – | 55.6% | -163.3% | -1.8% | -32.4% | -3,081.8% | -3,273.1% | -2,286.1% | -2,291.8% | -381.5% | -3,231.5% | -1,160.2% | -1,137.2% | -467.9% | -587.8% | -367.5% | -75.8% | -22.4% | -99.2% | -117.5% | 45.5% | 61.8% | -135.5% | 243.6% | 56.4% | |
| 3.6% | 4.0% | – | 6.3% | 6.5% | 15.2% | 15.0% | – | 8.0% | – | – | 5.6% | – | 6.7% | 12.6% | – | – | 0.6% | 1.7% | 0.3% | 0.3% | 143.4% | 500.4% | 482.6% | 474.5% | 62.4% | 315.6% | 126.0% | 133.5% | 55.1% | 88.0% | 99.8% | 51.3% | 40.4% | 65.0% | 88.1% | 29.5% | 18.2% | 81.6% | 74.0% | 35.1% | |
| -34.7% | -166.2% | – | -38.3% | -129.9% | -228.7% | -502.9% | – | -319.2% | – | – | -480.4% | – | -676.2% | -55.1% | – | – | 56.1% | -161.5% | -1.4% | -31.9% | -3,218.4% | -3,737.6% | -2,677.1% | -2,591.0% | -387.6% | -3,220.9% | -1,151.6% | -1,124.4% | -468.8% | -612.0% | -425.2% | -109.4% | -50.5% | -141.5% | -173.3% | 19.8% | 45.9% | -206.8% | 173.7% | 25.1% | |
| 7.4% | -3.3% | – | 10.7% | 12.9% | 9.8% | 12.9% | – | 7.2% | – | – | -3.2% | – | -0.7% | 0.6% | – | – | -0.1% | -1.7% | – | -0.3% | -143.4% | 464.5% | 391.0% | 299.2% | 0.4% | 304.9% | 126.0% | 133.6% | 0.0% | 7.8% | 0.1% | -2.0% | 0.0% | 0.2% | 0.2% | – | 0.1% | 0.2% | -660.3% | – | |
| -34.7% | -154.6% | – | -38.3% | -129.9% | -228.7% | -502.9% | – | -319.2% | – | – | -479.2% | – | -675.4% | -55.1% | – | – | 56.1% | -161.5% | -1.4% | -31.9% | -3,218.4% | -3,737.6% | -2,677.1% | -2,591.0% | -388.0% | -3,220.9% | -1,151.6% | -1,124.4% | -468.8% | -612.0% | -425.3% | -109.4% | -50.5% | -141.6% | -173.5% | 19.8% | 45.8% | -206.9% | 668.9% | 82.4% | |
| -29.3% | -160.1% | – | -31.3% | -122.7% | -211.9% | -486.0% | – | -309.3% | – | – | -474.3% | – | -664.8% | -54.1% | – | – | 56.3% | -160.4% | 1.6% | -28.7% | -3,180.3% | -3,178.1% | -2,147.6% | -2,071.3% | -316.3% | -2,862.2% | -1,008.7% | -973.0% | -384.6% | -515.6% | -320.0% | -56.1% | -8.8% | -74.2% | -82.6% | 50.1% | 64.7% | -122.8% | 54.7% | 38.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.